Opendata, web and dolomites


A Non-Invasive Test for Guiding Follow–up of Patients with CT-Detected Lung Nodules

Total Cost €


EC-Contrib. €






 LuMaSense project word cloud

Explore the words cloud of the LuMaSense project. It provides you a very rough idea of what is the project "LuMaSense" about.

portability    positive    prototype    16    immediately    countries    auxiliary    front    rationale    complexity    clinical    12    placement    urgent    marketable    optimal    portfolio    erc    translated    grant    plans    evaluation    completing    reduce    optimization    worldwide    screening    unnecessary    idea    programs    competitors    diag    save    96    sensitivity    group    mortality    cancer    noninvasive    operation    costly    action    nodule    commercially    false    specificity    fund    poc    lung    combination    ldct    invasive    economic    exists    malignant    rate    technique    off    detected    successful    covered    breath    complementary    health    relies    stand    24    speed    care    alone    spin    treatment    transform    usefulness    billion    conducting    delay    device    morbidity    healthcare    stages    ip    undergone    oriented    mature    technological    lc    market    patients    transfer    distinguish    tool    company    implication    powerful    utilizing    cancerous    ct   

Project "LuMaSense" data sheet

The following table provides information about the project.


Organization address
city: HAIFA
postcode: 32000

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2014-PoC
 Funding Scheme ERC-POC
 Starting year 2015
 Duration (year-month-day) from 2015-06-01   to  2016-11-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 


 Project objective

This PoC is a commercially-oriented spin-off from our “DIAG-CANCER” ERC project, addressing an urgent clinical need in the field of lung cancer (LC). The rationale behind this PoC is that CT-based LC screening programs are emerging in many countries worldwide. However, the high false positive rate of this technique (96% out of the 24% positive CT findings are non-cancerous) has been a major challenge in front those plans. This is because the CT-detected non-cancerous group has undergone unnecessary invasive procedures that are both costly and associated with significant morbidity and mortality. With this PoC project, we aim to increase the specificity of the LDCT based screening program by utilizing an auxiliary noninvasive breath test to distinguish between malignant and non-cancerous CT findings. The proposed breath test relies on a novel stand-alone device that provide an improved combination of speed, sensitivity, portability, low complexity, easy operation and low production cost. In order to transform our idea and current technology into a marketable device we propose taking several steps: (i) optimization of a prototype device and evaluation of its clinical usefulness through clinical studies; (ii) completing the IP portfolio of the device; and (iii) conducting detailed market research to identify the optimal placement in the healthcare market and possible competitors. After completing these stages, to be covered by the present grant, we propose to proceed to the technology transfer to a mature health care company or through complementary fund to advance the technological plans. If successful, the proposed PoC can be translated immediately into a powerful tool for the management of nodule-positive patients. It will both reduce the rate of unnecessary invasive procedures, and on the other hand, will avoid treatment delay when cancer exists. The economic implication of this action is a significant save of ~$12-16 billion for the healthcare system worldwide.


year authors and title journal last update
List of publications.
2016 Inbar Nardi-Agmon, Manal Abud-Hawa, Ori Liran, Naomi Gai-Mor, Maya Ilouze, Amir Onn, Jair Bar, Dekel Shlomi, Hossam Haick, Nir Peled
Exhaled Breath Analysis for Monitoring Response to Treatment in Advanced Lung Cancer
published pages: 827-837, ISSN: 1556-0864, DOI: 10.1016/j.jtho.2016.02.017
Journal of Thoracic Oncology 11/6 2019-07-22

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LUMASENSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LUMASENSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

MetTraC (2019)

Biocatalytic Methyltransferase Cascades

Read More  

PROFECI (2019)

Mediating the Future: The Social Dynamics of Public Projections

Read More  

MIMATOM (2020)

Paleomagnetism and rock-magnetism by Micro-Magnetic Tomography

Read More